Another major international collaboration for MICCN
15 February 2017
The Monash Institute of Cognitive and Clinical Neurosciences (MICCN) has signed another international Memorandum of Understanding (MOU), this time with the D’Or Institute for Research and Education (IDOR) in Rio de Janeiro, Brazil.
IDOR is a non-profit organisation aimed at promoting scientific and technological progress in healthcare. Its main sponsor, “Rede D’Or hospitais” group, is one of the largest hospital networks in Brazil, and includes a modern neuroimaging precinct with a three tesla MRI fully dedicated to research. The institute also has modern laboratory facilities where cutting-edge stem cell research is being performed by its 20 senior researchers, seven associate researchers, 14 postdocs, and approximately 80 doctorate, masters and scientific initiation students through academic partnerships with local universities.
Professor Leonardo Fontenelle, an internationally recognised psychiatrist and researcher in compulsivity/addiction, is assisting MICCN with facilitating this international collaboration.
The two Institutes – MICCN and IDOR - have complementary research strengths that will build capacity namely in the neuroscience of addiction and mental health in humans.
Activities will range from co-designing research studies aimed at fundamental questions pertinent to the field of neuropsychiatry, particularly in the area of addictive, compulsive and social behaviours; through to developing novel neuroscience and technology-based interventions (e.g. bio/neuro-feedback), and creating a critical mass to focus on innovations in industry with core experts from each Institution.
Professor Murat Yucel, Leader of MICCN’s Addiction Program, has visited IDOR four times to discuss topics of common interest. He said of the cognitive neuroscience alliance, “The collaboration between the two Institutes further facilitates the building of an international ‘network of excellence’ with leading research and industrial innovators, thereby further enhancing our capacity to impact global challenges. Our partnership with IDOR has already resulted in more than 20 peer-reviewed publications, two Brazilian grants, two presentations in European College of Neuropsychopharmacology meetings, and one joint presentation at the Brain, Behavior and Emotion Meeting in São Paulo, Brazil. We are excited about the future possibilities that this MOU will present.”
For more information on the D’Or Institute for Research and Education, visit http://www.idor.org/en/home.
MICCN also recently signed an MOU with Western University; more information can be found here.